Private Hospital Sealed After Woman, Child Die During Delivery In Fazilka

Fazilka : Dr Karamjeet Singh, practising at a private hospital in Arniwala sub-tehsil of Fazilka district, has been booked under Section 304 (causing death by negligence) of the IPC today as a pregnant woman and her child died during a delivery procedure on June 5.

The relatives of the deceased and a large number of villagers had been staging a protest by blocking the Fazilka-Malout road since Tuesday, demanding the registration of a murder case under Section 302 of the IPC against the doctor.

They were also seeking the registration of an FIR against Medical Officer (surgeon) Dr Kirti, posted at the Community Health Centre (CHC) in Dabwala Kalan village, who had referred the patient to the private hospital.

The protesters had kept the body of the deceased woman at the protest site. They lifted the dharna after Dr Babita, officiating Civil Surgeon, said Dr Kriti had been placed under suspension.

Meharban Singh said he had taken his pregnant wife Veerpal Kaur to the CHC on June 5 and a surgeon informed them that a delivery could not be performed there. The surgeon referred them to the private hospital and she, accompanied by Nachhatar Singh, took them there.

Dr Babita said the operation theatre and the hospital of Dr Karamjeet had been sealed. She said disciplinary action had been recommended against the surgeon and a three-member enquiry committee had been constituted.

Notably, the name of Dr Kirti figures in the FIR but no section of the IPC has been imposed on her on plea that criminal action shall be taken after the outcome of the enquiry being conducted by the Health Department.

  • Related Posts

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Hetero debuts semaglutide generic in emerging markets

    New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework